Dual-time-point FDG-PET/CT for the detection of hepatic metastases

Mol Imaging Biol. 2008 Nov-Dec;10(6):335-40. doi: 10.1007/s11307-008-0159-y. Epub 2008 Aug 16.

Abstract

Purpose: To prove the sensitivity of dual-time-point imaging with 18F-flourodeoxyglucose-positron emission tomography (18F-FDG-PET) of the liver to evaluate possible changes in the tumor-to-background ratio considering an improved detection rate of liver lesions.

Procedures: Image acquisition for the first whole-body scan started at a mean time point of 69 min (55-110 min). The mean time interval between the injection of 18F-FDG and the second delayed scan was 100 min (85-166 min).

Results: Of 90 proven liver metastases in 34 patients, the first scan detected 53 (59%) liver lesions correctly, whereas in the second, delayed scan 81 (90%) lesions were diagnosed correctly (p<0.001). The mean Standardized uptake values in the first and second delayed scan were 6.59 g/ml versus 8.09 g/ml, respectively (p<0.001). Tumor-to-background ratio of the first and second delayed scan were 2.0 and 2.7, respectively (p=0.04).

Conclusions: Dual-time-point-imaging of the liver showed a significant increase of tumor-to-background ratio and hypermetabolic lesion diameter. Although, 30% of all verified liver lesions could only be detected in the second delayed scan 10% of all malignant liver lesions were missed with FDG-PET.

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms
  • Colorectal Neoplasms
  • Female
  • Fluorine Radioisotopes
  • Fluorodeoxyglucose F18*
  • Humans
  • Liver Neoplasms / diagnostic imaging*
  • Liver Neoplasms / secondary
  • Male
  • Melanoma / diagnostic imaging
  • Melanoma / secondary
  • Middle Aged
  • Positron-Emission Tomography / methods*
  • Positron-Emission Tomography / statistics & numerical data
  • Radiopharmaceuticals
  • Sensitivity and Specificity
  • Time Factors
  • Tomography, X-Ray Computed / methods*
  • Tomography, X-Ray Computed / statistics & numerical data

Substances

  • Fluorine Radioisotopes
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18